Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years …. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both …

compares the health care systems of France, Germany, Japan and the Netherlands. Due to the complexity of the different … in den letzten Jahren zu starken Ausgabensteigerungen in den sozialen Krankenversicherungssystemen. Neben Deutschland … Krankenversicherung aufbaut: Deutschland, Frankreich, Japan und die Niederlande. Anhand definierter Kriterien werden die unterschiedlichen …

In Germany, cost-sharing for health care has been used as a financing mechanism since 1923. In this article, the … historical development of user charges in Germany since the 1980s is presented in more detail by type of private expenditure … of cost-sharing on equity, efficiency and health outcomes in Germany are presented. …